Research

No.

Company

Sector

Introduction

Official Website

1

Ucarer Taiwan

Health Care

Ucarer is the first third-party platform in Taiwan specializing in short-term home care services. Specifically designed for aging households, it leverages internet technology and e-commerce processes to provide a safe and convenient experience for selecting care services. Members are free to choose the most suitable home care service for their needs. The vision of Ucarer is to improve the quality of life for families with elderly members. The platform covers a wide range of care professionals, including caregivers, nurses, physical therapists, occupational therapists, and art therapists. With professional service design, it aims to meet diverse care needs and provide more home care options for all members. Unlike traditional staffing agencies, Ucarer uses an app-based matching system that empowers members to independently select caregivers. Members can first browse caregiver profiles, make online reservations and payments, and use the built-in “Ask” function to confirm service details in advance. Finally, a review and rating system ensures a safe and trustworthy service model.

https://ucarer.tw

2

Willsun Co., LTD

Beauty

Willsun Technology Co., Ltd. is building a vertical marketplace dedicated to the beauty industry. By leveraging a style-driven matching system and a content-to-booking model, 5233 enables consumers to seamlessly discover beauty services through short-form videos and posts, and complete reservations in just one click. The platform solves the fragmented, inefficient, and opaque process of finding and booking beauty services, while empowering beauty providers with digital tools to increase visibility, engagement, and conversion. Ultimately, 5233 aims to drive the digital transformation and growth of the beauty industry.

N/A

3

eXCELL Biotherapeutics Inc.

Health Care

We are a biopharmaceutical company with the mission to develop safe and effective xenogeneic cell cancer immunotherapeutics. Our studies demonstrate that xenogeneic cell immunotherapy technology is capable of stimulating the body’s immune system to process and recognize the tumor antigens as if they were foreign, generating an immune response able to attack the cancer due to the similarity between xeno-rejection and anti-tumor immunity. We believe this to be a broadly enabling platform technology that can be applied to the treatment of many types of cancers with xenogeneic tissue cells of the same histological type. It is supported by science that constructive xenogeneic cell immunotherapies can complement and address significant unmet needs in the current oncology treatment landscape. Specifically, our product candidates have the potential to optimize the clinical impact of systemic chemotherapeutic agents and checkpoint inhibitors while having a generally well-tolerated safety profile since normal xenogeneic tissue cells are used.  We have focused our initial development efforts upon therapeutic xenogeneic cells targeting bladder cancer and breast cancer. Unlike other immunotherapeutic agents that target a single pathway, causing over-reactive responses or easy tumor escape drawbacks, our xenogeneic cell approach elicits all out immune responses in concord ways which could have higher therapeutic efficacy, but less toxicity. Surgery and radiotherapy are local, tumor-directed treatments. Chemo-, endocrine, and targeted therapies are systemic, tumor directed treatments. Immune checkpoint inhibitors are systemic, body immunity directed treatments. For a comprehensive management on breast cancer, local, body immunity directed therapy is clearly lacking. Our novel therapy modality provides local and body targeting option with the potential to become a life-saving cellular medicine for cancer patients in dire needs.

https://www.excell10.com

4

fusionCare technology ltd.

Hardware

fusionCare with Taiwan's strengths of semiconductor and digital-healthcare (assistive-AI for images fusion of thermography/skeleton/acupoints/reflexology, etc)

N/A

5

Nexgene Company Co.,Ltd.

Health Care

Nexgene is the company developing the nature-derived multi-protein platform company, according to the protein functions, we expand the platform into 3 categories - Oncology, Neurodegeneration, Regenerative Medicine. This platform could develop different kinds of medicine depending on different biological tool- gene editing, humanization antibodies, and so on.

https://www.nexgene.com/

6

Colosscious Co., Ltd.

Information Technology

Colosscious empowers enterprise R&D and testing labs with structured data capture and AI-assisted workflows. Through Submission Forms and the AI-ELN, users can easily create traceable records, generate draft reports, and visualize results. Our platform has completed core module development and early-stage customer validation. We aim to evolve into an "AI as Lab Expert" all-in-one system—building the foundation for lab data integration and knowledge transformation.

https://www.colosscious.com/home

7

Garage Brain Science

Biotech

Garage Brain Science (GBS) is a biotech innovator creating the first integrated “structural health” platform to intercept chronic diseases before symptoms emerge. By combining ultra-sensitive diagnostics with protein-repair therapeutics, GBS directly addresses the $300B global preventive health market. Its proprietary diagnostic platform detects misfolded proteins—including markers for dementia, Parkinson’s, and pre-diabetes—with over 90% accuracy from a single drop of blood, enabling unprecedented early intervention. Reprofold®, the company’s lead therapeutic, corrects shared misfolding motifs across multiple proteins, offering a breakthrough solution for complex, multifactorial diseases. AI-driven systems, including Dr. Listening™ and Disease Origin Finder™, enhance precision, patient selection, and trial success. Backed by a decade of discovery and a growing IP portfolio, GBS is expanding into the U.S. to conduct clinical trials, forge pharma partnerships, and accelerate commercialization. With dual revenue tracks in diagnostics and therapeutics, GBS is positioned to transform preventive medicine and capture a leading role in longevity health.

https://www.garagebrainscience.com/about-us.html

8

Mosaic Media CO., LTD.

Sales and Marketing

Star Startup Marketing Co., Ltd., founded in 2024, is building a cross-border B2B SaaS platform powered by short-form video × AI smart customer service. We help traditional SMEs rapidly build brands and capture global orders. By replacing costly trade shows with video content and enabling AI-driven multilingual buyer engagement, our platform solves the pain points of manufacturers lacking marketing skills, foreign trade staff, and international exposure.

N/A